Multiple Choice
Warfarin resistance may be seen in patients with VCORC1 mutation, leading to:
A) Toxic levels of warfarin building up
B) Decreased response to warfarin
C) Increased risk for significant drug interactions with warfarin
D) Less risk of drug interactions with warfarin
Correct Answer:

Verified
Correct Answer:
Verified
Q1: A genetic variation in how the metabolite
Q2: Ultra-rapid metabolizers of drugs may have:<br>A) To
Q3: Genetic polymorphisms account for differences in metabolism,
Q4: Carbamazepine has a Black Box Warning recommending
Q6: A provider may consider testing for CYP2D6
Q7: Patients who have a poor metabolism phenotype
Q8: Rifampin is a nonspecific CYP450 inducer that
Q9: Up to 21% of Asians are ultra-rapid
Q10: Inhibition of P-glycoprotein by a drug such
Q11: Pharmacogenetic testing is required by the U.S.